Stereotaxis Inc. (NASDAQ:STXS) shares decreased -5.61% in last trading session and ended the day at $1.01. STXS Gross Margin is 73.00% and its has a return on assets of -16.10%. Stereotaxis Inc. (NASDAQ:STXS) quarterly performance is -29.86%.
On1 2 October, Stereotaxis, Inc. (NASDAQ:STXS), announced the worldwide launch of Respiratory Compensation, a new software feature of the Company’s Niobe® remote magnetic navigation system. Respiratory Compensation is designed to further enhance the quality and accuracy of Ablation History and the automation features of the Niobe system by compensating for respiratory motion during an ablation procedure.
Prudential Financial, Inc. (NYSE:PRU) ended the last trading day at $79.36. Company weekly volatility is calculated as 1.67% and price to cash ratio as 2.10. Prudential Financial, Inc. (NYSE:PRU) showed a weekly performance of 3.74%.
On 13 October, Prudential Financial, Inc. (NYSE:PRU) announced that it has promoted Ann Kappler and Margaret M. Foran to the rank of senior vice president. Both Kappler and Foran will continue to report to Tim Harris, who was recently appointed executive vice president and general counsel for the company.
On 21 October, Delphi Automotive PLC (NYSE:DLPH) shares decreased -0.44% and was closed at $81.91. DLPH EPS growth in last 5 year was -30.90%. Delphi Automotive PLC (NYSE:DLPH) year to date (YTD) performance is 13.69%.
Delphi Automotive PLC (NYSE:DLPH) will release its third quarter 2015 financial results on Oct. 29 and will hold an investor call the same day at 8:30 a.m. (ET). The call will be hosted by Delphi’s President and Chief Executive Officer, Kevin Clark, and Chief Financial Officer, Mark Murphy.
Exelixis, Inc. (NASDAQ:EXEL) shares decreased -0.54% in last trading session and ended the day at $5.49. EXEL Gross Margin is 91.30% and its has a return on assets of -64.10%. Exelixis, Inc. (NASDAQ:EXEL) quarterly performance is -6.63%.
Exelixis, Inc. (NASDAQ:EXEL) announced that its third quarter 2015 financial results will be released on Tuesday, November 10, 2015 after the markets close. At 5:00 p.m. EST / 2:00 p.m. PST, Exelixis management will host a conference call to discuss the results and provide a general business update. The conference call will be accessible via the Internet from the company’s website.
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) caters to the Healthcare space. Its weekly performance is 0.83%. On the last day of trading company shares ended up at $9.71. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) distance from 50-day simple moving average (SMA50) is -4.35%.
Cowen and Company began coverage on shares of Dicerna Pharmaceuticals (NASDAQ:DRNA) in a report issued on Tuesday morning, The Fly reports. The brokerage issued an outperform rating on the biopharmaceutical company’s stock.
Leave a Reply